SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-17-003209
Filing Date
2017-05-10
Accepted
2017-05-10 16:31:21
Documents
56
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 a5517010q.htm 10-Q 812789
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 10218
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 12707
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12795
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 4175
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 4217
  Complete submission text file 0001214659-17-003209.txt   3641930

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT anth-20170331.xml EX-101.INS 552457
8 XBRL TAXONOMY EXTENSION SCHEMA anth-20170331.xsd EX-101.SCH 35573
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anth-20170331_cal.xml EX-101.CAL 36400
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anth-20170331_def.xml EX-101.DEF 195007
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE anth-20170331_lab.xml EX-101.LAB 283718
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anth-20170331_pre.xml EX-101.PRE 249755
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 17830773
SIC: 2834 Pharmaceutical Preparations